Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)
Nephros (NEPH) recorded quarterly Liabilities from Discontinued Operations of 130000.0 in Q3 2022, up 80.56% quarter-over-quarter from 72000.0 in Q4 2021.
Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends
Nephros' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 130000.0 for Q3 2022.
- In Q3 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 130000.0; the TTM figure through Sep 2022 stood at 130000.0 (changed N/A YoY), while the FY2021 annual figure was 72000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was 130000.0 for Q3 2022 at Nephros, up from 72000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 130000.0 in Q3 2022 to a low of 72000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 130,000.00 |
| Sep 30, 2022 | 130,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |